RS Medical

What RS Medical does

RS Medical is a privately-held specialty medical device company founded in 1990 and headquartered in Vancouver, Washington. The company manufactures and distributes the RS-4i Plus, a prescription-grade home-use electrotherapy device that combines high-frequency Interferential Therapy (IFT) at 5000 Hz and Neuromuscular Electrical Stimulation (NMES) at 71 Hz in a single patented treatment known as Intersperse. Since 1990, RS Medical has served over 1.5 million patients with chronic musculoskeletal conditions including back pain, sciatica, frozen shoulder, diabetic neuropathy, and muscle spasms, supported by 30,000+ tracked patient outcome assessments since 2015 demonstrating an 84% pain relief rate after 30 days of treatment. Wearable conductive garments (RS-LBG, RS-FBG, RS-SG) accompany the device for assisted-free electrode placement.

The company operates a prescription-based, sales-led go-to-market model in which physicians, physical therapists, chiropractors, and pain specialists prescribe the RS-4i Plus, RS Medical ships the device directly to patients with personalized fitting and training, and RS Medical handles insurance billing on the patient's behalf. Revenue is generated through upfront hardware sales, recurring electrode pad resupply approximately every 30 days, and direct billing to commercial insurance, workers compensation carriers, personal injury payors, and government programs including the Veterans Health Administration under HCPCS codes E1399 (device), A4556 (electrodes), and E0731 (garments).

RS Medical serves four stakeholder segments: prescribing healthcare practitioners, end-patients with chronic pain, third-party payors, and the Veterans Administration. The company maintains a 120+ employee workforce with offices in Vancouver, WA and Buffalo, NY, distributes across all 50 US states plus Washington DC, and is not currently available internationally. No revenue, funding, ownership, or leadership-team details are publicly disclosed; the company is privately held with no identified institutional investors.

Name

RS Medical

Legal name

RS Medical

Website

https://rsmedical.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

101–250 employees

Short description

RS Medical is a privately-held US medical device company that manufactures and distributes the prescription-based RS-4i Plus home-use electrotherapy system, using patented Intersperse technology to treat chronic musculoskeletal pain in patients referred by healthcare practitioners.

Ownership category

akta.pro rank

Product category

Electrotherapy Pain Management Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industry

Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)

Keywords

• Electrotherapy devices
• Pain management
• Muscle rehabilitation
• Durable medical equipment
• Home medical devices

Headquarters

HQ city

Vancouver

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Device Sales: Sale of RS-4i Plus electrotherapy devices and related medical equipment (Pronex, ComforTrac, RS-4s) to patients with healthcare provider prescriptions. Devices billed through insurance or paid directly.
2. Electrode Pad Resupply: Recurring sales of disposable electrode pads that need replacement approximately every 30 days. Patients contact customer service to reorder supplies.
3. Insurance Billing: RS Medical handles insurance billing directly for patients, contacting primary and secondary insurance plans. Bills insurance carriers for products supplied and services rendered, with patient responsible for co-pay, co-insurance, and deductible amounts.
4. Workers' Compensation & Personal Injury: Products successfully billed to workers compensation and personal injury carriers in most states. Specific HCPCS codes used (E1399 for RS-4i Plus, A4556 for electrodes, E0731 for garments).

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

RS Medical manufactures and distributes prescription-grade home-use electrotherapy devices, most notably the RS-4i Plus, which combines Interferential Therapy (IFT) and Neuromuscular Electrical Stimulation (NMES) via patented Intersperse technology for pain relief and muscle rehabilitation. The company sells conductive wearable garments, replacement electrode pads, and complementary cervical traction devices (Pronex, ComforTrac), fulfilling orders and managing insurance billing directly on behalf of patients and healthcare practitioners across all 50 US states.

Differentiator

Problem solved

Functional benefit

Products and services

• RS-4i Plus A clinically proven, prescription-required, home-use electrotherapy device that combines 5000 Hz Interferential Therapy (IFT) for pain relief and 71 Hz Neuromuscular Electrical Stimulation (NMES) for muscle rehabilitation in a single 35-minute patented Intersperse treatment session. Designed for patients with chronic musculoskeletal pain.
• RS-LBG Low Back Garment Conductive wearable garment with pre-positioned electrode pads that enables patients to self-administer RS-4i Plus treatment on the lower back without assistance.
• RS-FBG Full Back Garment

Quantifiable outcome

• 84% of patients experience pain relief after 30 days of treatment (from 30,000+ patient assessments)
• +6 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Enovis (DJO Global / Chattanooga): Enovis owns the Chattanooga electrotherapy line (including Intelect and Rich-Mar devices) and is the largest direct competitor in clinical-grade interferential and NMES equipment. Comparable as both a manufacturer and US distributor of electrotherapy and rehabilitation devices serving physical therapists and pain specialists.
• Zynex Medical: Zynex prescribes and distributes TENS/EMS devices for chronic pain management directly to patients via healthcare providers, using a similar prescription-based US sales model. Comparable because it competes for the same payer-reimbursed electrotherapy prescriptions and recurring electrode resupply economics.
• NeuroMetrix: NeuroMetrix markets the Quell wearable TENS device for chronic pain, including fibromyalgia and lower-back pain. Comparable as a prescription-grade home-use neurostimulation company targeting the same chronic-pain patient population with a competing wearable technology.
• Mettler Electronics: Mettler manufactures clinical and home-use ultrasound, TENS, and NMES devices distributed to physical therapists and pain clinics. Comparable as a focused electrotherapy and rehabilitation equipment manufacturer with overlapping modality coverage (interferential, NMES, TENS).
• BioElectronics Corporation: BioElectronics produces ActiPatch and RecoveryRx pulsed shortwave therapy devices for musculoskeletal pain. Comparable as a smaller-scale competitor offering prescription and OTC electrotherapy alternatives aimed at the same chronic-pain conditions.

Broad incumbents

• Omron Healthcare: Omron Healthcare sells consumer-grade TENS units (e.g., Avail, PocketTens) for pain relief across retail and online channels. Comparable as a broad incumbent in personal pain-management devices, though Omron competes more on price/accessibility than on prescription-grade clinical evidence.
• Medtronic (Pain Therapies / Neuromodulation): Medtronic's Neuromodulation division sells implantable spinal cord and peripheral nerve stimulators for refractory chronic pain. Comparable as a broader incumbent addressing the same chronic-pain patient pathway, though at a higher-acuity, surgical end of the treatment continuum that RS Medical's at-home therapy avoids.
• Boston Scientific (Neuromodulation): Boston Scientific's Neuromodulation business markets Precision and WaveWriter spinal cord stimulators as well as emerging non-opioid pain interventions. Comparable as a broad incumbent competing for the chronic-pain treatment budget, primarily at the interventional end of the spectrum where RS Medical's home electrotherapy could serve as a step-therapy alternative.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

• Xx.com/rsmedical
• LinkedInlinkedin.com/company/rs-medical

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RS Medical